Anti-Spike RBD Antibody (Imdevimab)
Catalog No.
F1027
Anti-Spike RBD Antibody (Imdevimab)
Featured Products
Imdevimab (REGN10987) is a human monoclonal antibody that targets SARS-CoV-2, the virus that causes COVID-19. Imdevimab lacks efficacy against COVID-19 variants. Imdevimab can be used in combination with Casirivimab to effectively reduce viral load and improve symptoms.
144.14 kDa
Dry ice
2415933-40-1
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
REGN-10987, REGN 10987, Imdevimab
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Human
Unconjugated
Monoclonal
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Spike RBD
Please avoid freeze-thaw cycles.